Although SGLT2 is expressed in NSCLC cells (see Fig. S8) and canagliflozin inhibits glucose uptake in cancer cells, in that study, we found that the drug's anticancer action was independent of the extracellular glucose concentration [19]. The gene discussed is SLC5A2; the disease is cancer.